Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Lu, D.
  • Chen, S.
  • Tan, X. Y.
  • Li, N.
  • Liu, C. H.
  • Li, Z. J.
  • Liu, Z.
  • Stupack, D. G.
  • Reisfeld, Ralph
  • Xiang, Rong

publication date

  • July 2012

journal

  • Cancer Research  Journal

abstract

  • Fra-1 is a member of the Fos transcription factor family that is highly expressed in multiple cancers, playing important roles in transformation, proliferation, and metastasis. In this study, we observed an inverse correlation between the expression of Fra-1 in human stage II breast cancer tissues and the corresponding level of clinical chemoresistance. Extending these findings in vitro, we found that knockdown of Fra-1 in breast tumor cells was sufficient to confer resistance to doxorubicin and cyclophosphamide, whereas enhanced Fra-1 expression could render these cells chemosensitive. The tumor cell side population, which is enriched for cancer stem cells, was found to be associated with chemoresistance. Increased side population fractions were detected among tumor cell lines subjected to Fra-1 knockdown. In contrast, enhanced expression of Fra-1 was correlated with a decreased side population fraction, and significantly, this finding was recapitulated in vivo, where tumors with enhanced expression of Fra-1 were found to have blunted growth. Tumor cells subjected to Fra-1 knockdown grew faster and were larger in size. Taken together, our findings suggest that Fra-1 may be an important prognostic marker for breast cancer therapy.

subject areas

  • Animals
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Cell Line, Tumor
  • Cyclophosphamide
  • Disease Progression
  • Doxorubicin
  • Drug Resistance, Neoplasm
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Neoplastic Stem Cells
  • Prognosis
  • Proto-Oncogene Proteins c-fos
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0008-5472

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.can-11-2536

PubMed ID

  • 22586064
scroll to property group menus

Additional Document Info

start page

  • 3451

end page

  • 3456

volume

  • 72

issue

  • 14

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support